$REGN News Article - Late-Breaking Dupixent (dupi
Post# of 35791
(Total Views: 143)
Posted On: 09/05/2022 8:40:48 AM
$REGN News Article - Late-Breaking Dupixent (dupilumab) Data at ERS 2022 Show Consistent Efficacy and Safety Profile for Up to Two Years in Children Aged 6 to 11 Years with Moderate-to-severe Asthma https://marketwirenews.com/news-releases/late...06556.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼